To visit the old Ventura website, click here.
Ventura Wealth Clients Login here
Refer and earnSupport
logosearch
Create Account
hamburger
home
breadcrumbStocks
breadcrumbDishman Carbogen Amcis Ltd Share Price
breadcrumbValuation

Dishman Carbogen Amcis Ltd Fundamentals

info2
Compare peers arrow

Market Cap

4,393.85 Cr.

Face value

2.00

Book value

373.44

Div. yield

0.000

P/E ratio

42.16

P/B ratio

0.75

Debt/Eq.

0.36

Market Cap

4,393.85 Cr.

Face value

2.00

Book value

373.44

Div. yield

0.00%

P/E ratio

42.16

P/B ratio

0.75

Debt/Eq.

0.36
About Dishman Carbogen Amcis Ltd
arrow

Dishman Carbogen Amcis Limited (DCAL), incorporated in 1983, started out as a manufacturer of quaternary ammonium and phosphate compounds. Currently, the company is a fully integrated CRAMS player working with global pharmaceutical innovators. It has Read more ▾

IndustryPharmaceuticals & Drugs
SectorHealthcare
Top subsidiaries
CARBOGEN AMCIS (Shanghai) Co. Ltd.Carbogen Amcis AGDishman Medicare Ltd. (Formerly Known as Visible Investment Ltd.)Dishman Biotech Ltd.Dishman USA Inc Dishman Carbogen Amcis (Europe) Ltd.Dishman Carbogen Amcis (Japan) Ltd.Dishman Carbogen Amcis Technology AG
MANAGEMENT
right
Company Secretary & Compliance OfficerShrima Dave
Non Executive Independent DirectorMaitri Kirankumar Mehta
Non Executive Independent DirectorRajendra S Shah
Non Executive Independent DirectorSubir Kumar Das
Company Secretary & Compliance OfficerShrima Dave
left
Company Secretary & Compliance OfficerShrima Dave
Non Executive Independent DirectorMaitri Kirankumar Mehta
Non Executive Independent DirectorRajendra S Shah
Non Executive Independent DirectorSubir Kumar Das
Company Secretary & Compliance OfficerShrima Dave
Non Executive Independent DirectorMaitri Mehta
Non Executive Independent DirectorRajendra S Shah
Non Executive Independent DirectorSubir Kumar Das
Non Executive Independent DirectorAshok C Gandhi
Non Executive Independent DirectorSanjay S Majmudar
Global Managing DirectorArpit J Vyas
Whole Time DirectorDeohooti J Vyas
ChairmanJanmejay R Vyas
Non Executive Independent DirectorAshok C Gandhi
Non Executive Independent DirectorSanjay S Majmudar
Global Managing DirectorArpit J Vyas
Whole Time DirectorDeohooti J Vyas
ChairmanJanmejay R Vyas
Global Managing DirectorArpit J Vyas
Non Executive Independent DirectorSanjay S Majmudar
Non Executive Independent DirectorAshok C Gandhi
Non Executive Independent DirectorSubir Kumar Das
Non Executive Independent DirectorRajendra S Shah
ChairmanJanmejay R Vyas
Company Secretary & Compliance OfficerShrima G Dave
Whole Time DirectorDeohooti J Vyas
Non Executive Independent DirectorMaitri Mehta
Global Managing DirectorArpit J Vyas
Non Independent & Non Executive DirectorDhaval Shah
Whole Time DirectorDeohooti J Vyas
Company Secretary & Compliance OfficerShrima G Dave
Whole Time DirectorDeohooti J Vyas
Non Executive Independent DirectorRajendra S Shah
Global Managing DirectorArpit J Vyas
ChairmanJanmejay R Vyas
Non Executive Independent DirectorKulin N Shah
Non Executive Independent DirectorMaitri Mehta
Company Secretary & Compliance OfficerShrima G Dave
Independent DirectorKulin N Shah
Non Executive Independent DirectorHemantkumar J Bhatt
Non Executive Independent DirectorMargie S Parikh
Other detail of Dishman Carbogen Amcis Ltd
arrow
location
AddressDishman Corporate House Iscon - Bopal Road Ambli ,Ahmedabad ,Gujarat-380058.
phone
Telephone02717 420102 / 124
email
globe
MORE DETAILS
NSE Code21708
NSE SymbolDCAL
SeriesBE
ISININE385W01011
Dishman Carbogen Amcis Limited (DCAL), incorporated in 1983, started out as a manufacturer of quaternary ammonium and phosphate compounds. Currently, the company is a fully integrated CRAMS player working with global pharmaceutical innovators. It has a global presence with development and manufacturing facilities across Europe, India, and China. It provides end-to-end, integrated, high-value, niche CRAMS offering, right from process research & development to late-stage clinical and commercial manufacturing facilities along with the supply of Active Pharmaceutical Ingredients (API) to innovator pharmaceutical companies.
personal

Grow your wealth with more research recommendations

+91